Insights On Liquid Dose Manufacturing

  1. Vaccine Journey: Bench To Market 7/19/2023

    Vaccines are entering a new era. Gain insight into the market trends, projections, challenges, and potential solutions around the future of vaccine manufacturing.

  2. Engineering Advances In Needle Geometry To Accommodate Viscous Biologics 2/1/2023

    Explore the challenges faced in administering highly viscous biologics to patients via subcutaneous injection and how new special thin-wall needles are able to tackle them.

  3. Expanding Home-Based Care With A Next-Gen On-Body Delivery System 10/20/2023

    As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.

  4. Gloved Vs. Gloveless Filling Machines 7/18/2023

    When selecting an aseptic fill/finish machine, the choice to use a gloved or gloveless isolator will arise. To help with that decision, here are a few attributes to consider.

  5. Maximize Product Recovery In Bulk Filtration And Filling Flow Paths 12/15/2022

    Explore a fill system designed to automate product draining and recovery within a batch to standardize processes and minimize non-recoverable hold-up within the filtration and distribution flow path sections.

  6. How To Protect A Modern Silicone Oil-Sensitive Biologic Drug For Self-Injection Of 2.25mL 4/25/2023

    A customer experienced expensive project delays when they selected their “tried and tested” large volume, glass syringe system to package a drug to be used in an auto-injector for self-administration.

  7. Switching From Vials To PFS And Intravenous To Subcutaneous Formulations 7/25/2023

    Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.

  8. Electron Activated Dissociation Workflow For Biotherapeutics Characterization 8/28/2023

    Explore the benefits of an electron-activated dissociation middle-down workflow, including the ability to achieve high sequence coverages (70%-80%) of monoclonal antibody subunits in a single injection.

  9. Successful Planning: Process Liquid & Buffer Preparation 6/23/2023

    Obtain an accurate total cost of ownership assessment through understanding common operational inefficiencies, risks, and financial burdens associated with process liquid and buffer preparation.

  10. Ensure Speed And Success With Your Drug Delivery Project 5/18/2023

    Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.